These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10973323

  • 1. Combinatorial chemoprevention of intestinal neoplasia.
    Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, Discafani CM.
    Nat Med; 2000 Sep; 6(9):1024-8. PubMed ID: 10973323
    [Abstract] [Full Text] [Related]

  • 2. Combinations for cancer prevention.
    Gupta RA, DuBois RN.
    Nat Med; 2000 Sep; 6(9):974-5. PubMed ID: 10973312
    [No Abstract] [Full Text] [Related]

  • 3. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
    Hisamuddin IM, Wehbi MA, Chao A, Wyre HW, Hylind LM, Giardiello FM, Yang VW.
    Clin Cancer Res; 2004 Dec 15; 10(24):8357-62. PubMed ID: 15623613
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR, Leighton JA, Hirsch RE, Morrow JD, Weaver AL, Gendler SJ.
    Clin Cancer Res; 1999 Apr 15; 5(4):855-63. PubMed ID: 10213222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Chemoprevention of familial cancer].
    Ishikawa H.
    Gan To Kagaku Ryoho; 1997 Jun 15; 24(8):951-7. PubMed ID: 9212803
    [Abstract] [Full Text] [Related]

  • 8. Sulindac in familial adenomatous polyposis.
    Levy R.
    N Engl J Med; 2002 Aug 22; 347(8):615. PubMed ID: 12192027
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H.
    Int J Clin Oncol; 2004 Aug 22; 9(4):299-303. PubMed ID: 15375706
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancer.
    Evans JF.
    Am J Clin Oncol; 2003 Aug 22; 26(4):S62-5. PubMed ID: 12902858
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.
    Matsuhashi N, Nakajima A, Shinohara K, Oka T, Yazaki Y.
    Am J Gastroenterol; 1998 Nov 22; 93(11):2261-6. PubMed ID: 9820411
    [Abstract] [Full Text] [Related]

  • 19. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
    Raskov HH.
    Ugeskr Laeger; 2006 Jan 23; 168(4):359-62. PubMed ID: 16436235
    [No Abstract] [Full Text] [Related]

  • 20. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, Newmark HL, Chadburn A, Bertagnolli MM.
    Carcinogenesis; 1998 Jan 23; 19(1):87-91. PubMed ID: 9472698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.